Extracellular Domain Protein (ECD)

DIMA Biotechnology offers over 800 ECD proteins covering more than 600 single pass membrane protein targets. All the proteins were made using HEK293 mammalian cell secretion expression system to ensure the close-to-native structures and post-translational modifications of the target proteins. We also implemented a strict quality control process, including purity testing, antibody-drug interaction verification, freezing and thawing tests, thermal stability tests, etc. 

Applications:

  • Immunogens for antibody drug development
  • Reagents used for CAR-T positive cell monitoring
  • Reagents for antibody screening and functional testing
  • Reagents for antibody affinity measurement
View All ECD Proteins
protein

Immune checkpoints are a class of proteins that regulate tumor immune microenvironment.

They can be classified into two categories, costimulatory immune checkpoints, such as OX40, GITR, ICOS, etc.; and co-suppressive immune checkpoints, such as PD1, CTLA-4, etc.

Right now there are a number of FDA approved drugs on co-suppressive targets, such as Yervoy, anti-CTLA-4 monoclonal antibody, Keytruda, anti-PD-1 monoclonal antibody and Tecentriq, anti-PD-L1 monoclonal antibody.

pages-416107bc534d939 1

DIMA Biotechnology LTD provide a full spectrum of functional proteins of new CAR T-cell targets.

All the proteins were made by using HEK293 mammalian cell secretion expression system and we implemented a strict quality control process, including purity testing, antibody-drug interaction verification, freezing and thawing Tests, thermal stability tests, etc.

pages-cvsdvdfffffb 1

In recent years, the biopharmaceutical market is growing rapidly.

Compared with small molecule drugs, antibody drugs exhibit higher specificity and selectivity.

Therefore, it showed tremendous progresses in the treatment of hematological cancers and autoimmune diseases.

Due to complex tumor immune microenvironment, the development of therapeutic antibody drugs for solid tumor is more challenging.

Latest News

 

PSMA-前列腺癌放射性诊疗的重要靶点

前列腺特异性膜抗原 (PSMA [...]

GDF15 I 有望成为肥胖治疗的新兴靶点

据统计,目前已有多种针对 GD [...]

靶向BCMA用于多发性骨髓瘤无创成像和治疗的研究进展

近日,暨南大学附属第一医院核医 [...]

“核药”靶点知多少?

2024年,核药赛道的交易让人 [...]

CD73-癌症免疫疗法潜在靶点

2024年9月25日,天境生物 [...]

实体瘤靶点HER3/ERBB3-闪光赛道不仅仅是ADC

9月17日,第一三共和默沙东共 [...]

千亿美元的系统性红斑狼疮赛道上都有谁?

从市场情报提供商Future [...]

TRPV1-又一重要疼痛治疗靶点

还记得让美国科学家David [...]